tiprankstipranks
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

WVE Stock Latest News

Controversial doctor Vinay Prasad named CBER director, STAT reports
The FlyControversial doctor Vinay Prasad named CBER director, STAT reports
2d ago
DYN
RNA
WVE Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
WVE Upcoming Earnings Report: What to Expect?
2d ago
WVE
Wave Life Sciences: Positioned for Growth with Key Data Releases and Potential Accelerated Approvals
PremiumRatings
Wave Life Sciences: Positioned for Growth with Key Data Releases and Potential Accelerated Approvals
2d ago
WVE
Wave Life Sciences initiated with an Overweight at Cantor Fitzgerald
PremiumThe Fly
Wave Life Sciences initiated with an Overweight at Cantor Fitzgerald
9d ago
WVE
Wave Life Sciences initiated with an Overweight at Cantor Fitzgerald
PremiumThe Fly
Wave Life Sciences initiated with an Overweight at Cantor Fitzgerald
9d ago
WVE
JPMorgan biotech/Euro pharma analysts hold analyst/industry conference call
PremiumThe FlyJPMorgan biotech/Euro pharma analysts hold analyst/industry conference call
11d ago
WVE
BEAM
RBC sees Makary interview as potentially positive for biotech stocks
Premium
The Fly
RBC sees Makary interview as potentially positive for biotech stocks
17d ago
DYN
RNA
Wave Life Sciences price target lowered to $19 from $22 at B. Riley
Premium
The Fly
Wave Life Sciences price target lowered to $19 from $22 at B. Riley
28d ago
WVE
Wedbush starts RNA-focused standout Wave Life Sciences with an Outperform
PremiumThe Fly
Wedbush starts RNA-focused standout Wave Life Sciences with an Outperform
30d ago
WVE
Wave Life Sciences initiated with an Outperform at Wedbush
PremiumThe Fly
Wave Life Sciences initiated with an Outperform at Wedbush
30d ago
WVE
Wave Life Sciences’ Promising DMD Treatment Justifies Buy Rating Amid Positive Phase 2 Study Results
PremiumRatings
Wave Life Sciences’ Promising DMD Treatment Justifies Buy Rating Amid Positive Phase 2 Study Results
1M ago
WVE
Wave Life Sciences: Buy Rating Affirmed on Promising Clinical Results and Strategic Growth Plans
PremiumRatings
Wave Life Sciences: Buy Rating Affirmed on Promising Clinical Results and Strategic Growth Plans
1M ago
WVE
Wave Life Sciences Reports Positive Phase 2 Trial Results
PremiumCompany AnnouncementsWave Life Sciences Reports Positive Phase 2 Trial Results
1M ago
8K
WVE
Wave Life Sciences announces data from Phase 2 FORWARD-53 trial of WVE-N531
Premium
The Fly
Wave Life Sciences announces data from Phase 2 FORWARD-53 trial of WVE-N531
1M ago
WVE
Korro Bio price target lowered to $95 from $105 at RBC Capital
Premium
The Fly
Korro Bio price target lowered to $95 from $105 at RBC Capital
2M ago
WVE
KRRO
Promising Pipeline Developments and Strategic Advancements Support Buy Rating for Wave Life Sciences
PremiumRatings
Promising Pipeline Developments and Strategic Advancements Support Buy Rating for Wave Life Sciences
2M ago
WVE
Wave Life Sciences’ Earnings Call Highlights Progress and Challenges
PremiumCompany Announcements
Wave Life Sciences’ Earnings Call Highlights Progress and Challenges
2M ago
WVE
Positive Outlook on Wave Life Sciences: Promising Potential of WVE-007 in Obesity Treatment
PremiumRatings
Positive Outlook on Wave Life Sciences: Promising Potential of WVE-007 in Obesity Treatment
2M ago
WVE
Promising Outlook for Wave Life Sciences: Key Developments and Catalysts for 2025
PremiumRatings
Promising Outlook for Wave Life Sciences: Key Developments and Catalysts for 2025
2M ago
WVE
Wave Life Sciences Reports Strong Q4 2024 Results
PremiumCompany AnnouncementsWave Life Sciences Reports Strong Q4 2024 Results
2M ago
WVE
Wave Life Sciences Reports 2024 Financial Results and Updates
Premium
Company Announcements
Wave Life Sciences Reports 2024 Financial Results and Updates
2M ago
8K
WVE
Wave Life Sciences reports Q4 EPS 17c vs (15c) last year
Premium
The Fly
Wave Life Sciences reports Q4 EPS 17c vs (15c) last year
2M ago
WVE

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >